Knight Therapeutics Inc. KHTRF
Set alert
8.09 USD -0.15 -1.82%
At close · Oct 30
8.12 Day range 8.12
4.11 52-week range 8.31
- YTD
- +85.98%
- 1 year
- +95.88%
- Open
- 8.12
- Prev close
- 8.24
- Mkt cap
- 794.69M
- Vol
- 100
- Avg vol
- 2.10K
- EPS
- 0.11
- P/E
- 73.55
More statistics
- Low
- 8.12
- High
- 8.12
6M chart
Signals (27)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | May 21, 2026 | 5 months ago |
| RSI: Overbought | May 14, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| RSI: Overbought | May 7, 2026 | 5 months ago |
News
- Knight Therapeutics Q2 Earnings Call Highlights
- Knight Therapeutics Announces Repayment of Revolving Credit Facility
- Knight Therapeutics Announces Launch of TAVALISSE® in Mexico
- Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
- Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call Transcript
- Knight Therapeutics Reports First Quarter 2026 Results
- Knight Therapeutics Inc. announces voting results from the Annual General Meeting
- Knight Therapeutics Inc. (GUD:CA) Shareholder/Analyst Call Prepared Remarks Transcript
- Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call
- Knight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on KHTRF — it syncs with the Stock Master app.